Publisher
Springer Science and Business Media LLC
Reference63 articles.
1. Oronsky, B., Reid, T. R., Oronsky, A. & Carter, C. A. What’s New in SCLC? A Review. Neoplasia 19, 842–847 (2017).
2. De Santo, C. et al. The arginine metabolome in acute lymphoblastic leukemia can be targeted by the pegylated-recombinant arginase I BCT-100. Int J Cancer 142, 1490–1502 (2018).
3. Chow, A. K. et al. Anti-tumor efficacy of a recombinant human arginase in human hepatocellular carcinoma. Curr Cancer Drug Targets 12, 1233–1243 (2012).
4. Lam, T. L. et al. Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis. Pigment Cell Melanoma Res 24, 366–376 (2011).
5. Lam, S. K. et al. Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts. Respir Res 18, 80 (2017).
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献